Literature DB >> 21956894

Assessing vaccine safety communication with healthcare providers in a large urban county.

Dana Meranus1, Andy Stergachis, Jenny Arnold, Jeffrey Duchin.   

Abstract

PURPOSE: Vaccination is the primary public health tool for influenza control. Rapid assessment of the safety of any widely disseminated pandemic influenza vaccine is a public health priority. This study identifies practices, strengths, and weaknesses of vaccine-associated adverse event (AE) reporting to inform public health systems improvement.
METHODS: A survey was developed with local and state health agencies' input. After pre-testing, the survey was distributed online and via mail to a random sample of King County, WA, healthcare professionals, composed of 60 commercial vaccinator employees and school health nurses, 500 physicians, and 300 pharmacists.
RESULTS: The response rate was 36%. Results indicate that if an AE was suspected, 17% of respondents would not know how to report it, with 61% of respondents citing unclear definitions of a reportable AE as a barrier and 18% of respondents unaware of whose responsibility it is to report an AE.
CONCLUSION: Healthcare professionals who provide immunizations need additional information on their role in vaccine safety and AE reporting. Strengthening both passive and active reporting systems can enhance surveillance efforts during real-time events, such as mass immunization during a pandemic and other large-scale emergency countermeasure distribution programs.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2011        PMID: 21956894     DOI: 10.1002/pds.2245

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Preparedness and emergency response research centers: using a public health systems approach to improve all-hazards preparedness and response.

Authors:  Mary Leinhos; Shoukat H Qari; Mildred Williams-Johnson
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.

Authors:  Adriana Parrella; Michael Gold; Annette Braunack-Mayer; Peter Baghurst; Helen Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

3.  Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Authors:  Susann Muehlhans; Max von Kleist; Tatiana Gretchukha; Martin Terhardt; Ulrich Fegeler; Wolfgang Maurer; Leila Namazova-Baranova; Gerhard Gaedicke; Alexander Baranov; Barbara Rath
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

4.  Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania.

Authors:  Irsida Mehmeti; Erida Nelaj; Artan Simaku; Eugena Tomini; Silva Bino
Journal:  Heliyon       Date:  2017-06-20

5.  Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya.

Authors:  Calistus Wanjala Masika; Harrysone Atieli; Tom Were
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

6.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.